Trade Bristol Myers ^BMY

Bristol Myers Squibb ASCO Data Puts Oncology Pipeline In Investor Focus

JW Therapeutics CEO Says China Pharma Partnerships Unaffected by Tech Curbs

Uveal Melanoma Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

Tempus AI (TEM) Valuation Check After New Prostate Test Launch And Expanded Bristol Myers Squibb Collaboration

5 Best Retirement Stocks to Buy Now

Bristol Myers Squibb Company $BMY Shares Acquired by EverSource Wealth Advisors LLC

Legal & General Group Plc Buys 290,289 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Exome-wide association study of blood lipids in 1,158,017 individuals from diverse populations

Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial

Is Bristol-Myers Squibb (BMY) One of the Best Dividend Stocks to Invest in According to Hedge Funds?

Bristol Myers Squibb Company $BMY Position Trimmed by Associated Banc Corp

How Bristol Myers Squibb's Claude AI Deployment Across its Pipeline (BMY) Has Changed Its Investment Story

Mizuho Markets Cayman LP Invests $608,000 in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Position Raised by LSV Asset Management - Stock Observer

Bristol Myers Squibb Company $BMY Stock Position Raised by Legato Capital Management LLC - Stock Observer

Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages

Tempus AI, Inc. (TEM) and Bristol Myers Announce a Strategic Partnership

BMY Stock Sees Minor Dip After Six-Day Rally

Bristol-Myers Squibb Stock Rises on Anthropic AI Deal. Why This Could Actually Be a Key Upside Catalyst.

Q1 Rundown: Elanco (NYSE:ELAN) Vs Other Pharmaceuticals Stocks

1 Profitable Stock to Keep an Eye On and 2 We Brush Off

Cytokinetics Says MYKORZO Launch Tops Expectations as HCM Data Draws Praise - Stock Observer

Bristol Myers Squibb AI Deal With Anthropic And What It Means For BMY

23,109 Shares in Bristol Myers Squibb Company $BMY Acquired by Keudell Morrison Wealth Management

24,461 Shares in Bristol Myers Squibb Company $BMY Purchased by Ignite Planners LLC

Pzena Investment Management LLC Has $967.87 Million Holdings in Bristol Myers Squibb Company $BMY

IFP Advisors Inc Buys 18,060 Shares of Bristol Myers Squibb Company $BMY

Global Retirement Partners LLC Buys 60,544 Shares of Bristol Myers Squibb Company $BMY

Heritage Investors Management Corp Reduces Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Stock Holdings Increased by ABN Amro Investment Solutions

Contineum Therapeutics Touts PIPE-791 IPF Focus as Pain Data Hint at Wider Potential - Daily Political

Late-breaking Phase 3 SUCCESSOR-2 study results highlight po

How Investors Are Reacting To Tempus AI (TEM) Expanding Its AI‑Driven Oncology And Alzheimer's Toolkit

What's the future of AI in medicine research and discovery?

A Look At Bristol Myers Squibb (BMY) Valuation After Recent Share Price Strength And Mixed Earnings Figures

Fideuram Intesa Sanpaolo Private Banking S.P.A. Makes New Investment in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by HighTower Advisors LLC - Stock Observer

Sierra Summit Advisors LLC Buys Shares of 23,016 Bristol Myers Squibb Company $BMY - Daily Political

PNC Financial Services Group Inc. Sells 225,894 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Bristol Myers Squibb Company $BMY Stock Holdings Increased by ProShare Advisors LLC - Daily Political

Bristol Myers deploys Anthropic's Claude AI to accelerate drug discovery

Bristol Myers Squibb Partners with Anthropic to Accelerate Drug Discovery using AI, ETPharma

Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers

Bristol Myers to deploy Anthropic's Claude AI model to accelerate drug discovery

BMY Forms Partnership with Anthropic to Enhance AI Utilization

Bristol Myers to deploy Anthropic's Claude AI model to speed up drug discovery

Banque Cantonale Vaudoise Cuts Stock Position in Bristol Myers Squibb Company $BMY

Hengrui, BMS deal watershed moment for China biotech | BioWorld

Sotyktu's Psoriatic Arthritis Launch Builds Gradually in Month Two as Rheumatologists Continue to Take Measured Approach to TYK2 Adoption, According to Spherix Global Insights

Yanni & Associates Investment Advisors LLC Purchases Shares of 10,900 Bristol Myers Squibb Company $BMY

Resona Asset Management Co. Ltd. Sells 21,761 Shares of Bristol Myers Squibb Company $BMY

Handelsbanken Fonder AB Has $68.50 Million Stake in Bristol Myers Squibb Company $BMY

A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism

Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion

North Dakota State Investment Board Makes New Investment in Bristol Myers Squibb Company $BMY - Zolmax

BMY: Pipeline Execution And Macro Shifts Will Shape Future Risk Balance

The immunology of human breast cancer

BMY: Bristol Myers Squibb and Hengrui Pharma Strike $15.2B Licensing Deal

Kinsale Capital Group Inc. Buys 10,724 Shares of Bristol Myers Squibb Company $BMY - Zolmax

Leuthold Group LLC Buys New Stake in Bristol Myers Squibb Company $BMY

Beese Fulmer Investment Management Inc. Has $1.93 Million Position in Bristol Myers Squibb Company $BMY

Canada Post Corp Registered Pension Plan Acquires 22,986 Shares of Bristol Myers Squibb Company $BMY

ARS Investment Partners LLC Purchases 177,916 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Purchased by Kinsale Capital Group Inc. - Daily Political

2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down

Is Hengrui's US$15.2 Billion Alliance Reshaping the Investment Case for Bristol Myers Squibb (BMY)?

DNB Asset Management AS Increases Position in Bristol Myers Squibb Company $BMY - Zolmax

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Bristol Myers Squibb turns to China's Hengrui to replenish pipeline

Q2 EPS Forecast for Bristol Myers Squibb Lowered by Analyst - Stock Observer

AustralianSuper Pty Ltd Decreases Stock Holdings in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by Allworth Financial LP

Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons

Bristol-Myers Squibb Co at Bank of America Global Healthcare Conference Transcript

Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q1 Earnings?

Bristol Myers Squibb Company $BMY Shares Sold by Trek Financial LLC - Daily Political

Berkeley Capital Partners LLC Trims Stock Holdings in Bristol Myers Squibb Company $BMY - Daily Political

Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial

Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction

Bristol-Myers Shuts Down Lawsuit Over Celgene Investor Rights

10 Best Blue-Chip Stocks to Buy for the Long Term | Morningstar

China's Hengrui Partners with Bristol Myers Squibb in $15.2 Billion Licensing Deal, ETPharma

Dow Jones Top Company Headlines at 9 PM ET: Walmart Lays Off or Relocates About 1,000 Corporate Workers | SpaceX ... | Morningstar

Dow Jones Top Company Headlines at 7 PM ET: Walmart Lays Off or Relocates About 1,000 Corporate Workers | EBay ... | Morningstar

Bristol Myers Squibb signs $15.2 billion drug deal with China's Hengrui as patent cliff looms

Bristol Myers Squibb (BMY) Partners with Hengrui Pharma for $15.2B R&D Collaboration

Bristol Myers, Hengrui Pharma Partners On 13 Drug Programs In $15.2B Deal

Is BMY Undervalued? DCF Says Worth $74

Dow Jones Top Company Headlines at 7 AM ET: EBay Rejects GameStop's $56 Billion Takeover Proposal | JD.com ... | Morningstar

North American Morning Briefing: Futures Decline as Iran Peace Progress Weighs | Morningstar

China's Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS

Dow Jones Top Company Headlines at 5 AM ET: Bristol-Myers Squibb and China's Hengrui Pharma Forge Tie-Up | Sam ... | Morningstar

China's Jiangsu Hengrui, Bristol Myers Squibb sign deals worth up to $15.2b

Best CFD Brokers for Gold Trading in UAE in 2026

Best CFD Brokers for Gold Trading in South Africa (ZA) in 2026

Markets.com Review 2026: Complete Account Opening Guide, Deposit, Withdrawal & Demo Test

Forex Market Analysis: GBP/USD, EUR/USD, AUD/USD

What is the UAE stock market index: DFM, ADX and FTSE ADX Performance

S&P 500 Analysis: S&P 500 Trading Landscape Changes as Wall Street Reacts to Economic Data

Rivian Stock Price Prediction 2030: What South African Investors Need to Know about RIVN Stock?

AED/USD Exchange Rate Analysis: Why the AED is One of the Most Stable Currencies in Forex Right Now?

Top 10 best ETFs to invest in South Africa: Satrix 40 ETF, SYG500, STXDIV and more

Tesla (NASDAQ:TSLA) stock is rising: Can I buy Tesla stock in South Africa?

UAE’s Explosive AI Growth: UAE Tops Global AI Adoption for Third Straight Quarter at 70.1% Usage Rate

Gold Price Today, May 27: XAU/USD Holds Steady Around $4,510 as Traders Eye Fed Signals and Iran Talks

Gold Price Today, May 26: XAU/USD Holds Near $4,540 as Markets Weigh Fed Signals

SpaceX IPO Incoming: SpaceX Moves Forward with Planned Nasdaq IPO

Fed Leadership Change: Kevin Warsh Takes Over Federal Reserve at Critical Economic Moment

Gold Price Today, May 25: XAU/USD Opens Near $4,523 After Friday's Close at $4,509 on US-Iran Developments

Record-Breaking $500 Billion ETF Inflows in 2026: Historic Inflows Driven by US Stocks and EM Funds

Gold Price Today, May 22: XAU/USD Consolidates Near $4,520 Amid Fed Policy Uncertainty